LINDA GERHARDT: Open Payments
NPI 1497051171 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 13 payments from 8 companies in 2025. Trend: 2023 $194 · 2024 $377 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $69 |
| ABBVIE INC. | 3 | $68 |
| Amgen Inc. | 2 | $29 |
| Boston Scientific Corporation | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Veozah, VRAYLAR, OTEZLA, WATCHMAN FLX, UBRELVY, INJECTAFER, Ozempic, JOURNAVX.
Industry payments across MO — which companies pay providers there.
